Combination of a bioactive protein (highly purified recombinant human platelet derived growth factor, rhPDGF-BB) and an osteoconductive matrix (beta triacalcium phosphate, β-TCP) developed utilizing tissue engineering principles. GEM 21S® is intended for use as a completely synthetic grafting system for bone and periodontal regeneration.
Previously available from Osteohealth and American Regent.